Request Deal Involvement

Vesalius Biocapital led a €15m Series C round in HepaRegeniX.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

MC Services

pr advisors

MC Services

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

Linklaters

legal advisors

Linklaters

or

Principals

HEPAREGENIX

target

HEPAREGENIX

VESALIUS BIOCAPITAL PARTNERS SARL

bidder

VESALIUS BIOCAPITAL PARTNERS SARL

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

BOEHRINGER INGELHEIM VENTURE FUND

bidder

BOEHRINGER INGELHEIM VENTURE FUND

HIGH-TECH GRUENDERFONDS MANAGEMENT GMBH (HTGF)

bidder

HIGH-TECH GRUENDERFONDS MANAGEMENT GMBH (HTGF)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Vesalius Biocapital led a €15m Series C round in HepaRegeniX.